A limitation of our study is that only one endometrial cancer cell line was used as other lines tested lacked endogenous ERα hence generalisation of the findings to all endometrial cancers requires investigation in other cells as well as integration with the latest genomic datasets. This evidence concerns the gene ESR1 and endometrial cancer.